New research reveals that starting with a combination of three traditional disease-modifying antirheumatic drugs (called DMARDs) for treating early rheumatoid arthritis is more cost-effective long term, with comparable benefits, than using either an immediate or step-up approach with anti-tumor necrosis factor (called Anti-TNFs) drugs and methotrexate. The findings of the research was presented this week at the American College of Rheumatology Annual Meeting in San Diego. ...
Read MoreYou have just read an article categorized health
titled Anti-TNF Therapy Isn't as Cost Effective As Combination DMARDs in Treating Rheumatoid Arthritis.
Written by:
editor - Tuesday, October 29, 2013
There are currently no comments for "Anti-TNF Therapy Isn't as Cost Effective As Combination DMARDs in Treating Rheumatoid Arthritis"
Post a Comment